CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer

被引:0
|
作者
Asim Pervaiz
Michael Zepp
Saqib Mahmood
Doaa Mohamed Ali
Martin R. Berger
Hassan Adwan
机构
[1] University of Health Sciences,Institute of Biomedical and Allied Health Sciences
[2] Toxicology and Chemotherapy Unit,undefined
[3] German Cancer Research Centre (DKFZ),undefined
[4] German University of Cairo,undefined
来源
Cellular Oncology | 2019年 / 42卷
关键词
Breast cancer; Bone metastasis; CCR5; Maraviroc; Cell cycle arrest; Apoptosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:93 / 106
页数:13
相关论文
共 50 条
  • [41] Chemokine Receptor CCR5 Antagonist Maraviroc: Medicinal Chemistry and Clinical Applications
    Xu, Guoyan G.
    Guo, Jia
    Wu, Yuntao
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (13) : 1504 - 1514
  • [42] Use of maraviroc, the first CCR5 receptor antagonist, in HIV treatment regimens
    Kravchenko, A. V.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (11) : 125 - +
  • [43] Overcoming hERG affinity in the discovery of maraviroc; A CCR5 antagonist for the treatment of HIV
    Price, David A.
    Armour, Duncan
    de Groot, Marcel
    Leishman, Derek
    Napier, Carolyn
    Perros, Manos
    Stammen, Blanda L.
    Wood, Anthony
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2008, 8 (13) : 1140 - 1151
  • [44] Maraviroc, a CCR5 antagonist, prevents development of hepatocellular carcinoma in a mouse model
    Ochoa-Callejero, Laura
    Perez-Martinez, Laura
    Rubio-Mediavilla, Susana
    Oteo, Jose A.
    Martinez, Alfredo
    Blanco, Jose R.
    CANCER RESEARCH, 2012, 72
  • [45] The Expanding Therapeutic Perspective of CCR5 Blockade
    Vangelista, Luca
    Vento, Sandro
    FRONTIERS IN IMMUNOLOGY, 2018, 8
  • [46] The association between CCR5 Δ32 polymorphism and susceptibility to breast cancer
    Li, Junlong
    Peng, Yuan
    Liu, Hui
    Wu, Qiang
    ONCOTARGET, 2017, 8 (47) : 82796 - 82802
  • [47] CCR5 Antagonist Blocks Metastasis of Basal Breast Cancer Cells
    Velasco-Velazquez, Marco
    Jiao, Xuanmao
    De la Fuente, Marisol
    Pestell, Timothy G.
    Ertel, Adam
    Lisanti, Michael P.
    Pestell, Richard G.
    CANCER RESEARCH, 2012, 72 (15) : 3839 - 3850
  • [48] Assessment of CCR5 targeted nanotripod for breast cancer photothermal therapy
    Detering, Lisa
    Pang, Bo
    Zhao, Yongfeng
    Luehmann, Hannah
    Yang, Xuan
    Xia, Younan
    Liu, Yongjian
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [49] ASSOCIATION OF CCR5Δ32 MUTATION IN BREAST CANCER PATIENTS OF PAKISTAN
    Fatima, Faria
    Hameed, Abdul
    Sultan, Naheed
    Azhar, Abid
    Saleem, Saima
    Asia-Pacific Journal of Clinical Oncology, 2015, 11 : 171 - 171
  • [50] Activation of CCR5 in breast cancer regulates metabolism to promote tumorigenesis
    Fish, Eleanor N.
    Gao, Darrin
    CYTOKINE, 2017, 100 : 101 - 101